510(k) Report

510(k) · Cleared

Cleared

Progenix Plus

K082002510(k) TraditionalCleared Nov 24, 2008133-day reviewClass II21 CFR 888.3045

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medtronic Sofamor Danek · MQV Filler, Bone Void, Calcium Compound

Cleared on Nov 24, 2008 as substantially equivalent to K072265 (Medtronic Sofamor Danek, 2008) and 1 other predicate after a 133-day review. Its family tree reaches back 6 generations to 1997.

Decided
Nov 24, 2008
Review
133 days
Class
Class II
Product code
MQV
Recalls
None
Predicates
2

Its longest line of descent runs back 6 generations to K963562 (1997). 24 ancestors in all, the oldest K960978 (1996). No later device cites it as a predicate yet.

Other ancestors, by year cleared 2005: 6 other ancestors2007: 1 other ancestor2004: 4 other ancestors2003: 1 other ancestor2002: 1 other ancestor2001: 2 other ancestors2000: 1 other ancestor1998: 1 other ancestor1996: 1 other ancestorK963562 · Wright Plaster of Paris Pellets · Wrightmedicaltechnologyinc · 1997K020078 · Exactech Resorbable Bone Paste · Exactech, Inc. · 2004K040755 · Exactech Resorbable Room Temperature Bone Paste · Exactech, Inc. · 2004K043048 · Grafton Plus DBM Paste · Osteotech, Inc. · 2005 · recalledK060794 · Progenix DBM Putty and Paste · Medtronic Sofamor Danek · 2006K072265 · Progenix DMB Putty · Medtronic Sofamor Danek · 20081995200020052010
Other ancestors, by generation 1 generation back: 1 other ancestor2 generations back: 4 other ancestors3 generations back: 5 other ancestors4 generations back: 3 other ancestors5 generations back: 4 other ancestors6 generations back: 1 other ancestor K072265 · Progenix DMB Putty · Medtronic Sofamor Danek · 2008K060794 · Progenix DBM Putty and Paste · Medtronic Sofamor Danek · 2006K043048 · Grafton Plus DBM Paste · Osteotech, Inc. · 2005 · recalledK040755 · Exactech Resorbable Room Temperature Bone Paste · Exactech, Inc. · 2004K020078 · Exactech Resorbable Bone Paste · Exactech, Inc. · 2004K963562 · Wright Plaster of Paris Pellets · Wrightmedicaltechnologyinc · 1997−50
  1. Root · 6 generations backK963562 Wright Plaster of Paris PelletsWrightmedicaltechnologyinc · 1997
  2. 5 generations backK020078 Exactech Resorbable Bone PasteExactech, Inc. · 2004
  3. 4 generations backK040755 Exactech Resorbable Room Temperature Bone PasteExactech, Inc. · 2004
  4. 3 generations backK043048 Grafton Plus DBM PasteOsteotech, Inc. · 2005 · Recalled
  5. 2 generations backK060794 Progenix DBM Putty and PasteMedtronic Sofamor Danek · 2006
  6. 1 generation backK072265 Progenix DMB PuttyMedtronic Sofamor Danek · 2008
  7. This deviceK082002 Progenix PlusMedtronic Sofamor Danek · 2008
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K963562Wright Plaster of Paris PelletsWrightmedicaltechnologyinc1997—
−5K020078Exactech Resorbable Bone PasteExactech, Inc.2004—
−4K040755Exactech Resorbable Room Temperature Bone PasteExactech, Inc.2004—
−3K043048Grafton Plus DBM PasteOsteotech, Inc.200515
−2K060794Progenix DBM Putty and PasteMedtronic Sofamor Danek2006—
−1K072265Progenix DMB PuttyMedtronic Sofamor Danek2008—
0 (this device)K082002Progenix PlusMedtronic Sofamor Danek2008—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199610
199810
200010
200120
200210
200310
200440
200560
200710
FIG. 1 — Lineage of K082002, 1997–2008Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MQV device

  1. #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K072265Progenix DMB Putty
Summary page 2
…icles as well as a change in the amount of sodium alginate. The indications for PROGENIX® Plus will be identical to the previously cleared PROGENIX® product (K072265, SE 01/09108). IV. Indications PROGENIX® Plus is intended for use as a bone graft substitute in bony voids or gaps…
Medtronic Sofamor Danek2008—
*K051195Grafton DBM
Summary page 2
…to previously cleared bone void fillers such as PROGENIX® DBM Putty (Medtronic Sofamor Danek, K072265, SE 01/09/08)and GRAFTON® DBM Crunch (Osteotech, Inc., K051195, SE 12/16/05). VI. Osteoinductivity Potential All DBM used in the preparation of PROGENIX® Plus must induce bone f…
Osteotech, Inc.200530

Also cleared against K072265: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 11 years and passes through 4 companies; a new generation was cleared every 1.1 years on median.
  • 6 of the 24 ancestors have a recall of any class.
  • 1 other device also cites its predicate K072265.

How does its category compare?

All MQV devices

MQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · MQV

14in 2025

2007: 352008: 322009: 232010: 172011: 162012: 92013: 122014: 202015: 182016: 82017: 172018: 232019: 132020: 152021: 82022: 92023: 212024: 282025: 142026 (partial year): 5
2007high 35 (2007) · low 8 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQV

57in 2025

2007: 144 days median2008: 102 days median2009: 180 days median2010: 147 days median2011: 92 days median2012: 107 days median2013: 197 days median2014: 153 days median2015: 184 days median2016: 214 days median2017: 124 days median2018: 124 days median2019: 90 days median2020: 132 days median2021: 88 days median2022: 118 days median2023: 74 days median2024: 55 days median2025: 57 days median2026 (partial year): 96 days median
2007high 214 (2016) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MQV

1in 2025

2007: 52008: 32009: 12011: 62012: 32013: 22016: 12017: 12018: 22020: 12023: 32024: 22025: 12026 (partial year): 4
2007high 6 (2011) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MQV

57in 2025

2007: 672008: 712009: 812010: 682011: 1142012: 1492013: 2232014: 1112015: 1252016: 1062017: 1072018: 862019: 652020: 1262021: 1012022: 472023: 1202024: 682025: 57
2007high 223 (2013) · low 47 (2022)2025

MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735144567
200832102371
200923180181
201017147068
201116926114
201291073149
2013121972223
2014201530111
2015181840125
201682141106
2017171241107
201823124286
20191390065
2020151321126
20218880101
20229118047
202321743120
20242855268
20251457157
20265964—

What is it indicated for?

PROGENIX® Plus is intended for use as a bone graft substitute in bony voids or gaps of the skeletal system not intrinsic to the stability of the bony structure (i.e. spine, pelvis and extremities). The voids or gaps may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. PROGENIX® Plus provides a bone void filler that is resorbed/remodeled and is replaced by host bone during the healing process. The device may either be use alone or mixed with autograft bone and used as a bone graft extender.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K082002: Progenix Plus.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K082002

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026